Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever [Seeking Alpha]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Seeking Alpha
Despite a 6.5% dividend yield and low valuation multiples, PFE remains a value trap as share price performance lags and patent expiries loom. Recent M&A, including Seagen and Metsera, must deliver as COVID windfall fades and major assets like Eliquis and Prevnar approach patent cliffs. Hold rating reiterated: pipeline progress is promising, especially in obesity, but GLP-1 approvals are years away and earnings risk persists. Looking for a portfolio of ideas like this one? Members of Haggerston BioHealth get exclusive access to our subscriber-only portfolios. Learn More » PM Images/DigitalVision via Getty Images Investment Overview The New York-based pharma giant Pfizer Inc. ( PFE announced its Q4 and full-year earnings earlier today—let's take a quick look at the headline figures Revenues of $17.6bn in Q4 and earnings per share More on my IG service If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industr
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Trump administration to launch TrumpRx website for discounted drugs [Los Angeles Times (CA)]Los Angeles Times
- Bristol Myers forecasts upbeat 2026, expecting Eliquis price cut to pay off [Yahoo! Finance Canada]Yahoo! Finance Canada
- ??????????????????? - ??????????????????2026-2035? [CNET News]CNET News
- ??????????????????????????: 2032????19?8813?????????? [CNET News]CNET News
- Jim Cramer Expresses Concern About Pfizer Despite Its “Terrific Yield” [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 2/3/26 - Form 8-K
- 2/2/26 - Form 4
- 1/16/26 - Form 4
- PFE's page on the SEC website